In joint replacement patients, daily dose of aspirin could help prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), shows study.

The incidence of DVT was 19.2 percent (32.7 percent in total knee replacement and 5.6 percent in total hip replacement patients) which is below normal. None of the PE cases were fatal or severe, and there were no complications caused by the aspirin. Age and a high patient body mass index (BMI) were among the factors associated with a higher risk for DVT. Aspirin, along with the use of stockings and a foot pump, are safe and effective therapies in preventing DVT and PE in most joint replacement patients. Patients at high risk for DVT made require the use of anticoagulation therapies.
Source-Eurekalert